Linezolid Form-III | CAS 165800-03-3 - Request Quote
Linezolid Form-III
| SZ CAT No: | SZ-L025096 |
| CAS No | 165800-03-3 |
| Mol.F. | C16H20FN3O4 |
| Mol.Wt. |
337.4 |
| Inv. Status |
In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linezolid Form-III is chemically N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide (as per USP). Linezolid Form-III is supplied with detailed characterization data compliant with regulatory guideline. Linezolid Form-III can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linezolid.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 165800-03-3
Purchase 165800-03-3
Order 165800-03-3
Enquire 165800-03-3
price of 165800-03-3
165800-03-3 Supplier
165800-03-3 Manufacturer
165800-03-3 Exporter
buy high quality Linezolid Form-III
Purchase Linezolid Form-III
Linezolid Form-III suppliers
Linezolid Form-III manufacturers
Linezolid Form-III price
Order Linezolid Form-III
Enquire Linezolid Form-III
Linezolid Form-III cost
Linezolid Form-III Supplier
Linezolid Form-III Distributor
Linezolid Form-III for Method Validation
Linezolid Reference Standard
Linezolid Form-III for ANDA Filing
Linezolid Form-III for Forced Degradation Studies
Linezolid Form-III Identification Standards
Linezolid Form-III for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.